Evaluate

Evaluate radically transforms your confidence in strategic portfolio decisions.
We are the leading provider of commercial intelligence and predictive analytics for the global pharmaceutical industry.

We work with the world’s largest pharmaceutical corporations, financial services firms, management consultancies and service providers, as well as a wide range of innovative biotech and medtech companies.

From an overview of the broader market to a detailed product or company analysis, Evaluate's integrated platform is designed to take you from exploration to full understanding as quickly and accurately as possible. We help you:
- Identify competitor developments and likely time to market
- Forecast patient populations and product sales for a potential lead asset
- Undertake NPV assessments based on modelling discounted cash flows
- Manage clinical trial costing

Evaluate offers a pharmaceutical Consulting & Analytics service designed to help clients address unique scientific, clinical and commercial challenges. Our pharmaceutical consulting services provide insight into:
- Market Analysis & Competitor Intelligence
- Corporate Strategy & Franchise Planning
- Market Expansion & Forecasting
- Mergers & Acquisition
- New Product Development
- Market Access and Pricing
- Commercialization

Evaluate is now a Norstella company: an organization that helps to ease and accelerate patient access to life-changing therapies.